Clinical comparison of monophasic oral contraceptive preparations of gestodene/ethinyl estradiol and desogestrel/ethinyl estradiol
Latin American Oral Contraceptive Study Group - Contraception, 1994 - Elsevier
The efficacy, cycle control, subjective complaints, and safety of monophasic preparations of
the oral contraceptives containing gestodene 75 mcg plus ethinyl estradiol 30 mcg versus …
the oral contraceptives containing gestodene 75 mcg plus ethinyl estradiol 30 mcg versus …
Comparison of two monophasic oral contraceptives: gestodene/ethinyl estradiol versus desogestrel/ethinyl estradiol.
G Benagiano - International Journal of Fertility, 1989 - europepmc.org
The contraceptive efficacy, cycle control, safety, and subject acceptance of the new
contraceptive (OC) preparations containing gestodene (GTD) plus ethinyl estradiol (EE) are …
contraceptive (OC) preparations containing gestodene (GTD) plus ethinyl estradiol (EE) are …
Comparative study on the acceptability of two modern monophasic oral contraceptive preparations: 30 μg ethinyl estradiol combined with 150 μg desogestrel or 75 μg …
L Zichella, C Sbrignadello, A Tomassini… - Advances in …, 1999 - Springer
Cycle control and tolerability of two monophasic oral contraceptive pills containing 30 μg
ethinyl estradiol (EE) with either 150 μg desogestrel (DSG) or 75 μg gestodene (GSD) were …
ethinyl estradiol (EE) with either 150 μg desogestrel (DSG) or 75 μg gestodene (GSD) were …
Latin American experience with two low–dose oral contraceptives containing 30 μg ethinylestradiol/75 μg gestodene and 20 μg ethinylestradiol/150 μg desogestrel
S Bassol, A Alvarado, C Celis, MC Cravioto, O Peralta… - Contraception, 2000 - Elsevier
The objective of this study was to compare cycle control, efficacy and tolerance of an oral
contraceptive containing 20 μg ethinylestradiol and 150 μg desogestrel with a preparation …
contraceptive containing 20 μg ethinylestradiol and 150 μg desogestrel with a preparation …
A 13-month multicenter clinical experience of a low-dose monophasic oral contraceptive containing 20 μg ethinylestradiol and 75 μg gestodene in Latin American …
S Bassol, G Alvarado, RG Arreola, C Celis-Gonzalez… - Contraception, 2003 - Elsevier
This prospective, multicenter study was conducted to evaluate the contraceptive reliability,
cycle control and tolerability of a 21-day oral contraceptive regimen containing 20 μg …
cycle control and tolerability of a 21-day oral contraceptive regimen containing 20 μg …
Comparison of efficacy, cycle control, and tolerability of two low-dose oral contraceptives in a multicenter clinical study
J Endrikat, B Düsterberg, A Ruebig, C Gerlinger… - Contraception, 1999 - Elsevier
This study compares the contraceptive reliability, cycle control, and tolerability of two oral
contraceptive preparations containing 20 μg of ethinyl estradiol combined with either 75 μg …
contraceptive preparations containing 20 μg of ethinyl estradiol combined with either 75 μg …
Clinical experience with a low-dose oral contraceptive containing gestodene.
B Düsterberg, K Brill - … in Contraception: the Official Journal of the …, 1990 - europepmc.org
The monophasic combination preparation containing 30 micrograms ethinyl estradiol and
75 micrograms gestodene was tested for contraceptive reliability, cycle control and …
75 micrograms gestodene was tested for contraceptive reliability, cycle control and …
Safety and efficacy of a combined oral contraceptive: Gestodene 75 μg plus ethinyl estradiol 30 μg in Mexican women
J Garza-Flores, VV De Bourges, M Martinez… - Advances in …, 1994 - Springer
An open prospective clinical trial designed to evaluate the efficacy and safety of the
combined hormonal oral contraceptive (OC) containing 75 μg gestodene plus 30 μg ethinyl …
combined hormonal oral contraceptive (OC) containing 75 μg gestodene plus 30 μg ethinyl …
A twelve-month comparative clinical investigation of two low-dose oral contraceptives containing 20 μg ethinylestradiol/75 μg gestodene and 30 μg ethinylestradiol/75 …
J Endrikat, U Müller, B Düsterberg - Contraception, 1997 - Elsevier
The aim of this study was to compare contraceptive reliability, cycle control, and tolerance of
an oral contraceptive containing 20 μg ethinylestradiol (EE2) and 75 μg gestodene (GSD) …
an oral contraceptive containing 20 μg ethinylestradiol (EE2) and 75 μg gestodene (GSD) …
Efficacy, cycle control and side-effects of two monophasic combination oral contraceptives: Gestodene/ethinylestradiol and norgestimate/ethinylestradiol
P Affinito, M Monterubbianesi, M Primizia… - Gynecological …, 1993 - Taylor & Francis
Two monophasic oral contraceptives containing gestodene (GTD, 15 μg) and
ethinylestradiol (EE, 30 μg) or norgestimate (NGS, 250 μg) and EE (35 μg) were compared …
ethinylestradiol (EE, 30 μg) or norgestimate (NGS, 250 μg) and EE (35 μg) were compared …